Abstract
Objective: The aim of this study was to determine how lipoprotein lipase (LPL) and hepatic triacylglycerol
lipase (HTGL) activity relate to serum adiponectin levels. Research design and methods: Fifty-five hyperlipidemic Japanese men were recruited for this study. LPL and HTGL
activity in post-heparin plasma (PHP) was measured using Triton X-100 emulsified-[14 C] triolein. The remaining activity in the presence of 1M NaCl was defined as HTGL
activity. Serum adiponectin levels were determined by an enzyme-linked immunosorbent
assay system. Result: LPL activity had a positive relationship with HDL2 , but had no relation with HDL3 , while HTGL had positive relationship with HDL3 , but had no relationship with HDL2 . LPL activity showed a positive relationship [r = 0.345, p = 0.010] to serum adiponectin
levels, while and HTGL activity showed an inverse relationship [r = - 0.365 p = 0.006].
Multiple regression analysis with LPL and HTGL as dependent variables and age, BMI,
serum adiponectin and the homeostasis model assessment of insulin resistance (HOMA-IR)
as independent variables showed LPL and HTGL’s association to adiponectin did not
persist after adjustments for these covariants. However, the association of LPL activity
to HOMA-IR was found to persist after adjustments of age, BMI, and serum adiponectin.
Conclusions: There was a co-linearity between insulin sensitivity and adiponectin as well as insulin
sensitivity and LPL/HTGL activity.
Key words
Adiponectin · Hepatic triacylglycerol lipase · Lipoprotein lipase
References
1
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J M.
Positional cloning of the mouse obese gene and its human homologue.
Nature.
1994;
372
425-432
2
Hotamisligil G S, Shargill N S, Spiegelman B M.
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin
resistance.
Science.
1993;
259
87-91
3
Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S,
Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y.
Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease
in obesity.
Nat Med.
1996;
2
800-803
4
Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K.
cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1.
Biochem Biophys Res Commun.
1996;
221
286-289
5 Brunzell J D, Deeb S S.
Familial lipoprotein lipase deficiency, apo C-II deficiency and hepatic lipase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis
of inherited disease. New York; Mc Graw-Hill Inc 2001: 2789-2816
6 Jackson R L.
Lipoprotein lipase and hepatic lipase. In: Boyer PD (ed) Lipid Enzymology. Vol 16, The Enzymes. 3rd edition. New York; Academic
Press 1983: 141-181
7
Nilsson-Ehle P, Garfinkel A S, Schotz M C.
Lipolytic enzymes and plasma lipoprotein metabolism.
Ann Rev Biochem.
1980;
49
667-693
8
Hu E, Liang P, Spiegelman B M.
AdipoQ is a novel adipocyte-specific gene dysregulated in obesity.
J Biol Chem.
1996;
271
10 697-10 703
9
Scherer P E, Williams S, Fogliano M, Baldini G, Lodish H F.
A novel serum protein similar to C1q, produced exclusively in adipocytes.
J Biol Chem.
1995;
270
26 746-26 749
10
Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K.
cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1.
Biochem Biophys Res Commun.
1996;
221
286-289
11
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S,
Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R,
Kahn B B, Kadowaki T.
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating
AMP-activated protein kinase.
Nat Med.
2002;
8
1288-1295
12
Goldfine A B, Kahn C R.
Adiponectin: linking the fat cell to insulin sensitivity.
Lancet.
2003;
362
1431-1432
13
Jansson P A, Pellme F, Hammarstedt A, Sandqvist M, Brekke H, Caidahl K, Forsberg M,
Volkmann R, Carvalho E, Funahashi T, Matsuzawa Y, Wiklund O, Yang X, Taskinen M R,
Smith U.
A novel cellular marker of insulin resistance and early atherosclerosis in humans
is related to impaired fat cell differentiation and low adiponectin.
FASEB J.
2003;
17
1434-1440
14
Katsuki A, Sumida Y, Urakawa H, Gabazza E C, Murashima S, Matsumoto K, Nakatani K,
Yano Y, Adachi Y.
Plasma levels of adiponectin are associated with insulin resistance and serum levels
of triglyceride in Japanese metabolically obese, normal-weight men with normal glucose
tolerance.
Diabetes Care.
2003;
26
2964-2965
15
Kern P A, di Gregorio G B, Lu T, Rassouli N, Ranganathan G.
Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance,
and tumor necrosis factor-alpha expression.
Diabetes.
2003;
52
1779-1785
16
Cnop M, Havel P J, Utzschneider K M, Carr D B, Sinha M K, Boyko E J, Retzlaff B M,
Knopp R H, Brunzell J D, Kahn S E.
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma
lipoproteins: evidence for independent roles of age and sex.
Diabetologia.
2003;
46
459-469
17
Ezenwaka C E, Kalloo R, Uhlig M, Eckel J.
Relationship between adiponectin and metabolic variables in Caribbean offspring of
patients with type 2 diabetes mellitus.
Horm Metab Res..
2004;
36
238-242
18
Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H,
Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M,
Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y.
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2
diabetic patients.
Arterioscler Thromb Vasc Biol.
2000;
20
1595-1599
19
Pellme F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen M R, Jansson P A.
Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree
relatives of type 2 diabetic patients.
Diabetes.
2003;
52
1182-1186
20
Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M,
Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y.
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein
adiponectin.
Circulation.
1999;
100
2473-2476
21
The Expert Committee on the diagnosis and classification of diabetes mellitus .
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
Diabetes Care.
1997 Jul;
20
1183-1197
22
Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C.
Homeostasis model assessment: insulin resistance and beta-cell function from fasting
plasma glucose and insulin concentrations in man.
Diabetologia.
1985;
28
412-419
23
Kobayashi J, Shirai K, Saito Y, Yoshida S.
Lipoprotein lipase with a defect in lipid interface recognition in a case with type
I hyperlipidaemia.
Eur J Clin Invest.
1989;
19
424-432
24
Kobayashi J, Nishida T, Ameis D, Stahnke G, Schotz M C, Hashimoto H, Fukamachi I,
Shirai K, Saito Y, Yoshida S.
A heterozygous mutation (the codon for Ser447 → a stop codon) in lipoprotein lipase
contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia.
Biochem Biophys Res Commun.
1992;
182
70-77
25
Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I,
Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M,
Ohmoto Y, Funahashi T, Matsuzawa Y.
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.
Biochem Biophys Res Commun.
1999;
257
79-83
26
Semencovich C F, Wims M, Noe L, Etienne J, Chan L.
Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated
at posttranscriptional and posttranslational levels.
J Biol Chem.
1989;
264
9030-9038
27
Ong J M, Kirchgessner T G, Schotz M C, Kern P A.
Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase
in isolated rat adipocytes.
J Biol Chem.
1988;
263
12 933-12 938
28
Eckel R H, Yost T J, Jensen D R.
Alterations in lipoprotein lipase in insulin resistance.
Int J Obes Relat Metab Disord.
1995;
19 Suppl 1
S16-S21
29
Reynisdottir S, Angelin B, Langin D, Lithell H, Eriksson M, Holm C, Arner P.
Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings
in familial combined hyperlipidemia and insulin resistance syndrome.
Arterioscler Thromb Vasc Biol.
1997;
17
2287-2292
30
Panarotto D, Remillard P, Bouffard L, Maheux P.
Insulin resistance affects the regulation of lipoprotein lipase in the postprandial
period and in an adipose tissue-specific manner.
Eur J Clin Invest.
2002;
32
84-92
31
Rashid S, Watanabe T, Sakaue T, Lewis G F.
Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the
combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity.
Clin Biochem.
2003;
36
421-429
32
Baynes C, Henderson A D, Anyaoku V, Richmond W, Hughes C L, Johnston D G, Elkeles R S.
The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type
2 diabetes.
Diabet Med.
1991;
8
560-566
33
Riemens S C, van Tol A, Scheek L M, Dullaart R P.
Plasma cholesteryl ester transfer and hepatic lipase activity are related to high-density
lipoprotein cholesterol in association with insulin resistance in type 2 diabetic
and non-diabetic subjects.
Scand J Clin Lab Invest.
2001;
61
1-9
34
von Eynatten M, Schneider J G, Humpert P M, Rudofsky G, Schmidt N, Barosch P, Hamann A,
Morcos M, Kreuzer J, Bierhaus A, Nawroth P P, Dugi K A.
Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent
of systemic inflammation and insulin resistance.
Diabetes Care..
2004;
27
2925-2929
J. Kobayashi
Department of Lifestyle-related disease, Kanazawa University Graduate School of Medical
Science
Takara-machi 13-1 · Kanazawa 920-8640 · Japan
Phone: +81-76-265-2268
Fax: +81-76-234-4246
Email: Junji@med.kanazawa-u.ac.jp